KYOTO UNIVERSITY;NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
发明人:
Masatoshi HAGIWARA,Satoshi MOROOKA,Takamitsu HOSOYA,Suguru YOSHIDA
申请号：
US16284908
公开号：
US20190365762A1
申请日:
2019.02.25
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A pharmaceutical composition for neovascular diseases, a pharmaceutical composition for inhibiting an angiogenic growth factor, and use of these pharmaceutical compositions are provided.In one or more embodiments, a pharmaceutical composition contains as an active ingredient a low molecular weight compound that is able to suppress the expression of VEGF gene in cells or to reduce the production of VEGF protein from cells. In one or more embodiments, a pharmaceutical composition contains as an active ingredient a compound expressed by the following formula (I) or a prodrug thereof or pharmaceutically acceptable salts thereof.
